The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
European operations' revenue grew 58.4% to Rs 599.7 crore
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Subscribe To Our Newsletter & Stay Updated
